Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.820
-0.200 (-9.90%)
At close: Mar 9, 2026, 4:00 PM EDT
1.802
-0.018 (-1.01%)
After-hours: Mar 9, 2026, 7:03 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $75.07 million as of March 9, 2026. Its market cap has decreased by -78.35% in one year.
Market Cap
75.07M
Enterprise Value
60.65M
1-Year Change
-78.35%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $75.07M, a decrease of -94.37%. That is a compound annual growth rate of -41.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baird Medical Investment Holdings | 113.85M |
| Hyperfine | 103.97M |
| Neuronetics | 94.51M |
| Treace Medical Concepts | 92.13M |
| Xtant Medical Holdings | 86.80M |
| MaxCyte | 83.46M |
| Picard Medical | 79.60M |
| Sera Prognostics | 74.49M |